1 Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism
来源:TRENDS PHARMACOL SCI( P 0165-6147 E 1873-3735 ) 发表时间: 2016/01
类型:期刊论文 为本人加分:6981.836117
2 Novel activators and small-molecule inhibitors of STAT3 in cancer
来源:CYTOKINE GROWTH F R( P 1359-6101 E 1879-0305 ) 发表时间: 2019/10
类型:期刊论文 为本人加分:4159.649014
3 Promising Curcumin-based Drug Design: Mono-carbonyl Analogues of Curcumin[MACs]
来源:CURR PHARM DESIGN( P 1381-6128 E 1873-4286 ) 发表时间: 2013/04
类型:期刊论文 为本人加分:2753.615738
4 Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
来源:J EXP CLIN CANC RES( P 1756-9966 E ) 发表时间: 2019/01
类型:期刊论文 为本人加分:2700.115279
5 Synthesis and anti-inflammatory evaluation of novel mono-carbonyl analogues of curcumin in LPS-stimu..
来源:EUR J MED CHEM( P 0223-5234 E 1768-3254 ) 发表时间: 2010/12
类型:期刊论文 为本人加分:2228.540072
6 Synthesis of mono-carbonyl analogues of curcumin and their effects on inhibition of cytokine release..
来源:BIOORGAN MED CHEM( P 0968-0896 E 1464-3391 ) 发表时间: 2010/04
类型:期刊论文 为本人加分:2046.477828
7 FGF/FGFR signaling: From lung development to respiratory diseases
来源:CYTOKINE GROWTH F R( P 1359-6101 E 1879-0305 ) 发表时间: 2021/12
类型:期刊论文 为本人加分:1954.017774
贡献度:共同通讯作者
8 Dissecting the Role of the FGF19-FGFR4 Signaling Pathway in Cancer Development and Progression
来源:FRONT CELL DEV BIOL( P 2296-634X E ) 发表时间: 2020/02
类型:期刊论文 为本人加分:1842.901205
9 Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy
来源:J EXP CLIN CANC RES( P E 1756-9966 ) 发表时间: 2019/07
类型:期刊论文 为本人加分:1594.755975
10 Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of ..
来源:MOL CARCINOGEN( P 0899-1987 E 1098-2744 ) 发表时间: 2019/04
类型:期刊论文 为本人加分:1570.193527